ORIC
ORIC Pharmaceuticals Inc

826
Mkt Cap
$1.18B
Volume
1.77M
52W High
$14.93
52W Low
$3.90
PE Ratio
-6.34
ORIC Fundamentals
Price
$10.98
Prev Close
$12.11
Open
$12.02
50D MA
$10.23
Beta
1.62
Avg. Volume
1.43M
EPS (Annual)
-$1.83
P/B
2.62
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Oric Pharmaceuticals (NASDAQ:ORIC) Shares Down 6.8% - Time to Sell?
Oric Pharmaceuticals (NASDAQ:ORIC) Shares Down 6.8% - Here's Why...
MarketBeat·10h ago
News Placeholder
More News
News Placeholder
Oric Pharmaceuticals (NASDAQ:ORIC) Sees Large Volume Increase - What's Next?
Oric Pharmaceuticals (NASDAQ:ORIC) Sees Strong Trading Volume - Should You Buy...
MarketBeat·2d ago
News Placeholder
Oric Pharmaceuticals, Inc. (NASDAQ:ORIC) Receives Average Rating of "Moderate Buy" from Analysts
Oric Pharmaceuticals, Inc. (NASDAQ:ORIC - Get Free Report) has received a consensus rating of "Moderate Buy" from the fourteen brokerages that are currently covering the stock, Marketbeat.com...
MarketBeat·7d ago
News Placeholder
Short Interest in Oric Pharmaceuticals, Inc. (NASDAQ:ORIC) Grows By 19.6%
Oric Pharmaceuticals, Inc. (NASDAQ:ORIC - Get Free Report) saw a large growth in short interest during the month of December. As of December 31st, there was short interest totaling 21,469,843 shares...
MarketBeat·9d ago
News Placeholder
Oric Pharmaceuticals (NASDAQ:ORIC) Sees Large Volume Increase - Still a Buy?
Oric Pharmaceuticals (NASDAQ:ORIC) Sees Strong Trading Volume - Still a Buy...
MarketBeat·14d ago
News Placeholder
Precision Killers: Why Big Pharma is Betting Billions to Beat a $170B Patent Cliff
Precision Killers: Why Big Pharma is Betting Billions to Beat a $170B Patent Cliff Precision Killers: Why Big Pharma is Betting Billions to Beat a $170B Patent Cliff PR Newswire VANCOUVER, BC, Jan...
PR Newswire·15d ago
News Placeholder
Wedbush Reaffirms Outperform Rating for Oric Pharmaceuticals (NASDAQ:ORIC)
Wedbush reaffirmed an "outperform" rating and set a $20.00 price target on shares of Oric Pharmaceuticals in a research note on Tuesday...
MarketBeat·16d ago
News Placeholder
Oric Pharmaceuticals (NASDAQ:ORIC) Trading 7.8% Higher - Should You Buy?
Oric Pharmaceuticals (NASDAQ:ORIC) Trading 7.8% Higher - Here's What Happened...
MarketBeat·19d ago
News Placeholder
Oric Pharmaceuticals, Inc. (NASDAQ:ORIC) Given Consensus Rating of "Moderate Buy" by Brokerages
Oric Pharmaceuticals, Inc. (NASDAQ:ORIC - Get Free Report) has earned an average rating of "Moderate Buy" from the thirteen brokerages that are covering the firm, MarketBeat reports. One analyst has...
MarketBeat·1mo ago
News Placeholder
Oric Pharmaceuticals (NASDAQ:ORIC) Stock Price Down 7.5% - Here's What Happened
Oric Pharmaceuticals (NASDAQ:ORIC) Trading Down 7.5% - Here's What Happened...
MarketBeat·1mo ago
<
1
2
...
>

Latest ORIC News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.